Consensus statement on human immunodeficiency virus pre-exposure prophylaxis in China.

Jun-jie XU; Xiao-jie Huang; Xin-chao Liu; Li-ming Wang; Yao-kai Chen; Hui Wang; Fu-jie Zhang; Hao WU; Tai-sheng LI; Meng-jie Han; Fang Zhao; Hai-bo Ding; Jun-yi Duan; Gen-shen Sheng; Hong Shang

Return

Consensus statement on human immunodeficiency virus pre-exposure prophylaxis in China.

Author: Jun-Jie XU ¹ ; Xiao-Jie HUANG ² ; Xin-Chao LIU ³ ; Li-Ming WANG ⁴ ; Yao-Kai CHEN ⁵ ; Hui WANG ⁶ ; Fu-Jie ZHANG ⁴ ; Hao WU ² ; Tai-Sheng LI ³ ; Meng-Jie HAN ⁷ ; Fang ZHAO ⁶ ; Hai-Bo DING ¹ ; Jun-Yi DUAN ² ; Gen-Shen SHENG ⁸ ; Hong SHANG ¹
Author Information

1. National Health Commission (NHC) Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China.
2. Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
3. Department of Infection, Peking Union Medical College Hospital, Beijing 100730, China.
4. Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
5. Chongqing Public Health Medical Center, Chongqing 400036, China.
6. Department of Infectious Diseases, National Clinical Center for Infectious Diseases, Third People's Hospital of Shenzhen (Second Affiliated Hospital of Southern University of Science and Technology), Shenzhen, Guangdong 518112, China.
7. National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
8. Shenzhen Rainbow 258 Centre For Men, Shenzhen, Guangdong 518001, China.
Publication Type:Journal Article
MeSH: Anti-HIV Agents/therapeutic use*; China; Consensus; HIV; HIV Infections/prevention & control*; Humans; Pre-Exposure Prophylaxis
From: Chinese Medical Journal 2020;133(23):2840-2846
CountryChina
Language:English